Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|December 19, 2019
Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic MalignanciesElisa Zaghi, Michela Calvi, Clara Di Vito, et al.Frontiers in Immunology|April 8, 2017
Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical CorrelatesJoanna Mikulak, Clara Di Vito, Elisa Zaghi, et al.Journal of Leukocyte Biology|January 16, 2019
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapyElisa Zaghi, Michela Calvi, Emanuela Marcenaro, et al.AIDS (London, England)|September 20, 2017
Natural killer cells in HIV-1 infection and therapyJoanna Mikulak, Ferdinando Oriolo, Elisa Zaghi, et al.Seminars in Immunology|May 16, 2019
NK cells to cure cancerClara Di Vito, Joanna Mikulak, Elisa Zaghi, et al.International Journal of Molecular Sciences|October 20, 2018
Ether-Oxygen Containing Electrospun Microfibrous and Sub-Microfibrous Scaffolds Based on Poly(butylene 1,4-cyclohexanedicarboxylate) for Skeletal Muscle Tissue EngineeringNora Bloise, Emanuele Berardi, Chiara Gualandi, et al.Cancers|December 1, 2020
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate LymphocytesSilvia Pesce, Sara Trabanelli, Clara Di Vito, et al.Frontiers in Immunology|February 11, 2022
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant CyclophosphamideGiuseppe Lia, Clara Di Vito, Stefania Bruno, et al.Frontiers in Immunology|January 25, 2024
Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivationClara Di Vito, Nicolò Coianiz, Michela Calvi, et al.Transplantation and Cellular Therapy|April 5, 2021
Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological MalignanciesLuca Castagna, Viviana Valli, Inna Timofeeva, et al.Pageof 2